Report ID: SQMIG35G2218
Report ID:
SQMIG35G2218 |
Region:
Global |
Published Date: August, 2024
Pages:
219
|
Tables:
128 |
Figures:
77
North America dominated the market and held a revenue share of over 59.0% in 2022, which can be attributed to the region's enhanced awareness of the efficacy of digital biomarkers as well as the region's substantial number of key market players, significant product launches, increase in investment in research and development, and growing acceptance of smart devices. A few other key factors for this area to forecast market expansion include the increasing number of initiatives to improve healthcare IT and the existence of healthcare programmers. Additionally, it is anticipated that the market in North America will be driven by the strategic initiatives of the region's market participants and significant R&D expenditure.
The fastest growth in the digital biomarker market is anticipated in Europe, where a growing number of chronically ill patients are driving demand for real-time monitoring and disease diagnosis. Additionally, during the forecast period, market expansion is being fueled by developed healthcare infrastructure in European countries and a strong emphasis on R&D activities, which is anticipated to propel market expansion.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35G2218